Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II – III invasive breast cancer: the OOTR-N001 study

Author： Chow Louis WC   Tung Stewart Y   Ng Ting-Ying   Im Seock-Ah   Lee Min-Hyuk   Yip Adrian YS   Toi Masakazu   Glück Stefan  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.3, 2013-03, pp. : 299-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast Cancer: A Phase II Study

By Sarid David  

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 691-701

Adis International

Access to resources Recommend Favorite

Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer

By Davide Radice   Alberto Redaelli  

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 69-75

Adis International

Access to resources Recommend Favorite

Gemcitabine/epirubicin/docetaxel effective in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1471, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

By Sunpaweravong Patrapim   Magree Lyn   Rabinovitch Rachel   Bunn Paul   Kelly Karen  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 213-221

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent treatment with epirubicin, docetaxel and cisplatin shows activity in metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite